Literature DB >> 15254276

Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A.

Songkai Liu1, Maria Asparuhova, Vincent Brondani, Ingrid Ziekau, Thomas Klimkait, Daniel Schümperli.   

Abstract

Human immunodeficiency virus 1 (HIV-1) multiplication depends on a cellular protein, cyclophilin A (CyPA), that gets integrated into viral particles. Because CyPA is not required for cell viability, we attempted to block its synthesis in order to inhibit HIV-1 replication. For this purpose, we used antisense U7 small nuclear RNAs (snRNAs) that disturb CyPA pre-mRNA splicing and short interfering RNAs (siRNAs) that target CyPA mRNA for degradation. With dual-specificity U7 snRNAs targeting the 3' and 5' splice sites of CyPA exons 3 or 4, we obtained an efficient skipping of these exons and a strong reduction of CyPA protein. Furthermore, short interfering RNAs targeting two segments of the CyPA coding region strongly reduced CyPA mRNA and protein levels. Upon lentiviral vector-mediated transduction, prolonged antisense effects were obtained for both types of antisense RNAs in the human T-cell line CEM-SS. These transduced CEM-SS cells showed a delayed, and for the siRNAs also reduced, HIV-1 multiplication. Since the two types of antisense RNAs function by different mechanisms, combining the two approaches may result in a synergistic effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254276      PMCID: PMC484190          DOI: 10.1093/nar/gkh715

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 3.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

4.  Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.

Authors:  L Gorman; D Suter; V Emerick; D Schümperli; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Host cyclophilin A mediates HIV-1 attachment to target cells via heparans.

Authors:  A C Saphire; M D Bobardt; P A Gallay
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

Review 6.  Approaches to gene therapy for human immunodeficiency virus infection.

Authors:  G L Buchschacher; F Wong-Staal
Journal:  Hum Gene Ther       Date:  2001-06-10       Impact factor: 5.695

7.  Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation.

Authors:  Andrew C S Saphire; Michael D Bobardt; Philippe A Gallay
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

9.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Authors:  Gustavo Tiscornia; Oded Singer; Masahito Ikawa; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

10.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Authors:  A Steinkasserer; R Harrison; A Billich; F Hammerschmid; G Werner; B Wolff; P Peichl; G Palfi; W Schnitzel; E Mlynar
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more
  22 in total

Review 1.  Regulation of alternative splicing by short non-coding nuclear RNAs.

Authors:  Amit Khanna; Stefan Stamm
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 2.  Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy.

Authors:  Rachel Nlend Nlend; Kathrin Meyer; Daniel Schümperli
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  Protection of shrimp Penaeus monodon from WSSV infection using antisense constructs.

Authors:  Sajad Ahanger; Supriyanka Sandaka; Deepika Ananad; Madhu K Mani; Ravinder Kondadhasula; Chandra Sekhar Reddy; Makesh Marappan; Rajendran K Valappil; Kshitish C Majumdar; Rakesh K Mishra
Journal:  Mar Biotechnol (NY)       Date:  2013-08-03       Impact factor: 3.619

Review 4.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

5.  Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.

Authors:  Helen S Christensen; Aïcha Daher; Kaitlin J Soye; Lisa B Frankel; Marina R Alexander; Sébastien Lainé; Sylvie Bannwarth; Chi L Ong; Sean W L Chung; Shahan M Campbell; Damian F J Purcell; Anne Gatignol
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 6.  Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

Authors:  Annemieke Aartsma-Rus; Gert-Jan B van Ommen
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

Review 7.  U7 snRNA: A tool for gene therapy.

Authors:  Ankur Gadgil; Katarzyna Dorota Raczyńska
Journal:  J Gene Med       Date:  2021-02-23       Impact factor: 4.565

8.  An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.

Authors:  Eugenio Fernandez Alanis; Mirko Pinotti; Andrea Dal Mas; Dario Balestra; Nicola Cavallari; Malgorzata E Rogalska; Francesco Bernardi; Franco Pagani
Journal:  Hum Mol Genet       Date:  2012-02-23       Impact factor: 6.150

9.  The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.

Authors:  Udayan Chatterji; Michael Bobardt; Suganya Selvarajah; Feng Yang; Hengli Tang; Noayo Sakamoto; Gregoire Vuagniaux; Tanya Parkinson; Philippe Gallay
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

10.  Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.

Authors:  Dimitrios Vlachakis; Georgia Tsiliki; Athanasia Pavlopoulou; Maria G Roubelakis; Spyridon Champeris Tsaniras; Sophia Kossida
Journal:  Evol Bioinform Online       Date:  2013-05-16       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.